Research keywords (3):
melanoma
, regulatory B cell
, tumor immunity
Research theme for competitive and other funds (3):
2021 - 2024 全身性強皮症におけるTLR7およびTLR9の役割についての解析
2018 - 2021 腫瘍免疫における制御性B細胞の役割および作用機序についての解析
2016 - 2018 腫瘍免疫におけるRegulatory B細胞の役割についての解析
Papers (43):
Chenyang Wang, Kyosuke Oishi, Tadahiro Kobayashi, Ko Fujii, Motoki Horii, Natsumi Fushida, Tasuku Kitano, Shintaro Maeda, Yuichi Ikawa, Akito Komuro, et al. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis. International journal of molecular sciences. 2024. 25. 11
Wah Wah Aung, Chenyang Wang, Jia Xibei, Motoki Horii, Kie Mizumaki, Miyu Kano, Ai Okamura, Tadahiro Kobayashi, Takashi Matsushita. Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma. Journal of Dermatological Science. 2021. 101. 3. 174-184
Tadahiro Kobayashi, Sara Matsumoto, Kyoko Shimizu, Miho Miyake, Shintaro Maeda, Yasuhito Hamaguchi, Takashi Matsushita. Discrepancy in responses to dabrafenib plus trametinib combination therapy in intracranial and extracranial metastases in melanoma patients. Journal of Dermatology. 2021. 48. 2. e82-e83
Natsumi Fushida, Tadahiro Kobayashi, Kyosuke Oishi, Shintaro Maeda, Takashi Matsushita, Yasunari Mizumoto, Kazuhiko Takehara, Yasuhito Hamaguchi. A case of anti-NXP2 antibody-positive dermatomyositis with improvement of clinical symptoms and disappearance of autoantibody after resection of uterine cancer. European Journal of Dermatology. 2020. 30. 5. 612-613
Tumor-infiltrating CD5+ regulatory B1 cells suppress melanoma tumor immunity via inhibiting cytokine production of tumor-infiltrating CD8+ T cells
(International Investigative Dermatology 2018 2018)
Dual aspects of B cells in tumor immunity; B cells are capable of positive and negative regulation for tumor immunity against B16F10 melanoma
(41th Annual Meeting of JSID 2016)